...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ACB of Zen shares
5
Sep 13, 2018 08:08AM

https://www.resverlogix.com/about/history

2
Sep 13, 2018 11:34AM
Share
New Message
Please login to post a reply